FDA Inspection 1224895 — Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. (FDF Site)
The FDA completed an inspection of Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. (FDF Site) on Nov 10, 2023 in Nanjing. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Nov 10, 2023
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Nanjing (China)